Dr. Alan Bernstein is the Professor and Director of Global Health, University of Oxford (Brasenose College). He received his Ph.D. from the University of Toronto in Medical Biophysics under Dr. Jim Till. Following postdoctoral research at the Imperial Cancer Research Fund Laboratories (London (UK), he joined the Ontario Cancer Institute, University of Toronto. In 1985, he joined the Samuel Lunenfeld Research Institute and served as its Director of Research from 1994-2000. In 2000, Dr. Bernstein became the founding president of the Canadian Institutes of Health Research (CIHR), where he led the transformation of health research in Canada (2000 - 2007). He then served as executive director of the Global HIV Vaccine Enterprise (2008 - 2011), an international alliance of funders charged with accelerating development of an HIV vaccine.  He then served as President and CEO of CIFAR where he launched new programs including the Global Competition for New Ideas, the CIFAR Azrieli Global Scholars Program, and the pan Canadian Program in AI.  Author of over 200 peer reviewed publications and more than 60 articles in the lay press, he is best known for his many contributions to science and science policy. He serves on advisory and review boards for governments, foundations and research institutions around the world and is a Senior Fellow of Massey College and Distinguished Fellow of the Munk School of Global Affairs. His contributions to science and science policy have been recognized with numerous awards and honorary degrees including the McLaughlin Medal of the RSC, honoree of the Public Policy Forum; Gairdner International Wightman Awardee; induction into the Canadian Medical Hall of Fame; and the 2017 Henry Friesen International Prize in Health Research. He is a Companion of the Order of Canada and the Order of Ontario.